The lncRNA MIAT, also termed as Gomafu, was first identified to be associated with myocardial infarction in a genome-wide association study.4 Increasing evidence has suggested that MIAT is involved in various diseases and cellular processes, including myocardial infarction,8 microvascular dysfunction,5 age-related cataract,9 and neurogenic commitment.10 Recently, Crea et al.11 reported that MIAT could be exploited as a new biomarker and therapeutic target for neuroendocrine prostate cancer. This evidence concerns the gene MIAT and myocardial infarction.